References
Zimmerman HJ: Hepatotoxicity. The Adverse Effects of Drugs and Other Chemicals on the Liver, 2nd ed. Philadelphia, Lippincott Williams & Wilkins, 1999
Blaise M, Pateron D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL: Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 20:34–38, 1994
Rimola A, Garcia-Tsao G, Navasa M, Piddock LJV, Planas R, Bernard B, Inadomi JM, International Ascites Club: Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document. J Hepatol 32:142–153, 2000
Verhamme M, Ramboer C, Van De Bruaue P, Inderadjaja N: Cholestatic hepatitis due to an amoxycillin/clavulanic acid preparation. J Hepatol 9:260–264, 1989
Nathani MG, Mutchnick MG, Tynes DJ, Ehrinpreis MN: An unusual case of amoxicillin/clavulanic acid-related hepatotoxicity. Am J Gastroenterol 93:1363–1365, 1998
Reddy KR, Brillant P, Schiff ER: Amoxicillin-clavulanate potassium-associated cholestasis. Gastroenterology 96:1135–1141, 1989
Larrey D, Vial T, Micaleff A, Babary G, Moricheau-Brauchnt M, Michel H, Benhamou JP: Hepatitis associated with amoxycillin-clavulanic acid combination. Report of 15 cases. Gut 33:368–371, 1992
Hautekeete ML, Brenard R, Horsmans Y, Henrion J, Verbist L, Derue G, Druez P, Omar M, Kockx M, Hubens H, Haber I, Rahier J, Geubel AP: Liver injury related to amoxycillinclavulanic acid: Interlobular bile-duct lesions and extrahepatic manifestations. J Hepatol 22:71–77, 1995
Hebbard GS, Smith KG, Gibson PR, Bhathal PS: Augmentininduced jaundice with a fatal outcome. Med J Aust 156:285–286, 1992
Danan G, Bénichou C: Causality assessment on adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 46:1323–1330, 1993
Maria VAJ, Victorino RMM: Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 26:664–669, 1997
Benazzi F: Risperidone-induced hepatotoxicity. Pharmacopsychiatry 31:241, 1998
Medicine Control Agency: Cholestatic jaundice with coamoxiclav. Curr Probl Pharmacov 19:2, 1993
Ragg M: MaLam and augmentin. Lancet 2:487, 1993
Hautekeete ML, Horsmans Y, Van Waeyenberge C, Demanet C, Henrion J, Verbist L, Brenard R, Sempoux C, Michielsen PP, Yap PSH, Rahier J, Geubel AP: HLA association of amoxicillin-clavulanate-induced hepatitis. Gastroenterology 117:1181–1186, 1999
Westphal J-F, Brogard J-M: Drug administration in chronic liver disease. Drug Safety 17:47–73, 1997
Schenker S, Martin RR, Hoyumpa AM: Antecedent liver disease and drug toxicity. J Hepatol 31:1098–1105, 1999
Garcia-Rodriguez LA, Stricker BH, Zimmerman HJ: Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 156:1327–1332, 1996
Grange JD, Amiot X, Grange V, Gutmann L, Biour M, Bodin F, Poupon R: Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: A prospective study of twenty-seven cases in cirrhotic patients. Hepatology 11:360–364, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andrade, R.J., Lucena, I., Fernández, C. et al. CASE REPORT: Hepatotoxicity in Patients with Cirrhosis, an Often Unrecognized Problem. Dig Dis Sci 46, 1416–1419 (2001). https://doi.org/10.1023/A:1010627518254
Issue Date:
DOI: https://doi.org/10.1023/A:1010627518254